Literature DB >> 19432443

Use of protonless NMR spectroscopy to alleviate the loss of information resulting from exchange-broadening.

Shang-Te Danny Hsu1, Carlos W Bertoncini, Christopher M Dobson.   

Abstract

We report here the use of protonless NMR spectroscopy to extract structural information under biologically relevant conditions when conventional proton-detection NMR spectroscopy fails due to the loss of labile proton resonances. By direct (13)C detection, correlations between nonlabile nuclei of a given biomolecule can be determined with high resolution, which becomes particularly useful when the system of interests is sensitive to solvent exchange at elevated temperatures, such as intrinsically disordered proteins. Human alpha-synuclein, which is associated with Parkinson's disease, is used as a model system to illustrate the usefulness of protonless NMR spectroscopy in recovering hitherto missing spectral information.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432443     DOI: 10.1021/ja902307q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  25 in total

1.  Speeding up sequence specific assignment of IDPs.

Authors:  Wolfgang Bermel; Ivano Bertini; Isabella C Felli; Leonardo Gonnelli; Wiktor Koźmiński; Alessandro Piai; Roberta Pierattelli; Jan Stanek
Journal:  J Biomol NMR       Date:  2012-06-10       Impact factor: 2.835

2.  HN-NCA heteronuclear TOCSY-NH experiment for (1)H(N) and (15)N sequential correlations in ((13)C, (15)N) labelled intrinsically disordered proteins.

Authors:  Christoph Wiedemann; Nishit Goradia; Sabine Häfner; Christian Herbst; Matthias Görlach; Oliver Ohlenschläger; Ramadurai Ramachandran
Journal:  J Biomol NMR       Date:  2015-08-18       Impact factor: 2.835

3.  High-dimensionality 13C direct-detected NMR experiments for the automatic assignment of intrinsically disordered proteins.

Authors:  Wolfgang Bermel; Isabella C Felli; Leonardo Gonnelli; Wiktor Koźmiński; Alessandro Piai; Roberta Pierattelli; Anna Zawadzka-Kazimierczuk
Journal:  J Biomol NMR       Date:  2013-11-08       Impact factor: 2.835

4.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

5.  Random coil chemical shift for intrinsically disordered proteins: effects of temperature and pH.

Authors:  Magnus Kjaergaard; Søren Brander; Flemming M Poulsen
Journal:  J Biomol NMR       Date:  2011-01-15       Impact factor: 2.835

6.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

7.  Optimized co-solute paramagnetic relaxation enhancement for the rapid NMR analysis of a highly fibrillogenic peptide.

Authors:  Nur Alia Oktaviani; Michael W Risør; Young-Ho Lee; Rik P Megens; Djurre H de Jong; Renee Otten; Ruud M Scheek; Jan J Enghild; Niels Chr Nielsen; Takahisa Ikegami; Frans A A Mulder
Journal:  J Biomol NMR       Date:  2015-03-28       Impact factor: 2.835

8.  Using NMR Chemical Shifts to Determine Residue-Specific Secondary Structure Populations for Intrinsically Disordered Proteins.

Authors:  Wade M Borcherds; Gary W Daughdrill
Journal:  Methods Enzymol       Date:  2018-10-22       Impact factor: 1.600

9.  Detection of disordered regions in globular proteins using ¹³C-detected NMR.

Authors:  Felicia L V Gray; Marcelo J Murai; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Protein Sci       Date:  2012-12       Impact factor: 6.725

10.  Nitrogen detected TROSY at high field yields high resolution and sensitivity for protein NMR.

Authors:  Koh Takeuchi; Haribabu Arthanari; Ichio Shimada; Gerhard Wagner
Journal:  J Biomol NMR       Date:  2015-10-23       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.